9:00 – 9:20 AM |
Welcome | Pre-test | Background on antiamyloid therapies
Charles Bernick, MD, MPH |
9:20 – 9:50 AM |
Translating clinical trial results to the clinic
Babak Tousi, MD |
9:50 – 10:20 AM |
Who is the right patient for anti-amyloid therapies?
Lakeshia Gibson, MD |
10:20 – 10:30 AM |
Break
|
10:30 – 11:30 AM |
Surveillance for amyloid-related imaging abnormalities (ARIA)
Dylan Wint, MD |
11:30 – 12:00 PM |
Logistics of starting anti-amyloid therapy
Maileen Ulep, PhD, MSN, APRN, FNP-BC |
12:00 – 12:10 PM |
Conclusion | Post-test | Adjourn
Faculty |
